DENTSPLY SIRONA Inc.

DY2.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DY2.DE stands at 3.8B. In comparison, CBHD.DE has a market cap of 12.9B. Regarding current trading prices, DY2.DE is priced at €17.77, while CBHD.DE trades at €57.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DY2.DE currently has a P/E ratio of 8.34, whereas CBHD.DE's P/E ratio is 24.18. In terms of profitability, DY2.DE's ROE is -0.24%, compared to CBHD.DE's ROE of +0.25%. Regarding short-term risk, DY2.DE is less volatile compared to CBHD.DE. This indicates potentially lower risk in terms of short-term price fluctuations for DY2.DE.Check CBHD.DE's competition here

DY2.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DY2.DE stands at 3.8B. In comparison, HS2.DE has a market cap of 9.4B. Regarding current trading prices, DY2.DE is priced at €17.77, while HS2.DE trades at €74.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DY2.DE currently has a P/E ratio of 8.34, whereas HS2.DE's P/E ratio is 22.93. In terms of profitability, DY2.DE's ROE is -0.24%, compared to HS2.DE's ROE of +0.12%. Regarding short-term risk, DY2.DE is more volatile compared to HS2.DE. This indicates potentially higher risk in terms of short-term price fluctuations for DY2.DE.Check HS2.DE's competition here

DY2.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DY2.DE stands at 3.8B. In comparison, HO1.DE has a market cap of 0. Regarding current trading prices, DY2.DE is priced at €17.77, while HO1.DE trades at €61.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DY2.DE currently has a P/E ratio of 8.34, whereas HO1.DE's P/E ratio is 86.74. In terms of profitability, DY2.DE's ROE is -0.24%, compared to HO1.DE's ROE of +0.08%. Regarding short-term risk, DY2.DE is less volatile compared to HO1.DE. This indicates potentially lower risk in terms of short-term price fluctuations for DY2.DE.Check HO1.DE's competition here

DY2.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DY2.DE stands at 3.8B. In comparison, ZIM.DE has a market cap of 0. Regarding current trading prices, DY2.DE is priced at €17.77, while ZIM.DE trades at €94.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DY2.DE currently has a P/E ratio of 8.34, whereas ZIM.DE's P/E ratio is 233.84. In terms of profitability, DY2.DE's ROE is -0.24%, compared to ZIM.DE's ROE of +0.05%. Regarding short-term risk, DY2.DE is more volatile compared to ZIM.DE. This indicates potentially higher risk in terms of short-term price fluctuations for DY2.DE.Check ZIM.DE's competition here

DY2.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DY2.DE stands at 3.8B. In comparison, 0HV.DE has a market cap of 0. Regarding current trading prices, DY2.DE is priced at €17.77, while 0HV.DE trades at €39.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DY2.DE currently has a P/E ratio of 8.34, whereas 0HV.DE's P/E ratio is N/A. In terms of profitability, DY2.DE's ROE is -0.24%, compared to 0HV.DE's ROE of +0.01%. Regarding short-term risk, DY2.DE is more volatile compared to 0HV.DE. This indicates potentially higher risk in terms of short-term price fluctuations for DY2.DE.Check 0HV.DE's competition here